TY - JOUR
T1 - Trajectories of suicidal ideation over 6 months among 482 outpatients with bipolar disorder
AU - Köhler-Forsberg, Ole
AU - Madsen, Trine
AU - Behrendt-Møller, Ida
AU - Sylvia, Louisa
AU - Bowden, Charles L.
AU - Gao, Keming
AU - Bobo, William V.
AU - Trivedi, Madhukar H.
AU - Calabrese, Joseph R.
AU - Thase, Michael
AU - Shelton, Richard C.
AU - McInnis, Melvin
AU - Tohen, Mauricio
AU - Ketter, Terence A.
AU - Friedman, Edward S.
AU - Deckersbach, Thilo
AU - McElroy, Susan L.
AU - Reilly-Harrington, Noreen A.
AU - Nierenberg, Andrew A.
N1 - Funding Information:
This research was funded by the Agency for Healthcare Research and Quality (AHRQ): 1R01HS019371-01.
Publisher Copyright:
© 2017 Elsevier B.V.
PY - 2017/12/1
Y1 - 2017/12/1
N2 - Introduction Suicidal ideation occurs frequently among individuals with bipolar disorder; however, its course and persistence over time remains unclear. We aimed to investigate 6-months trajectories of suicidal ideation among adults with bipolar disorder. Methods The Bipolar CHOICE study randomized 482 outpatients with bipolar disorder to 6 months of lithium- or quetiapine-based treatment including other psychotropic medications as clinically indicated. Participants were asked at 9 visits about suicidal ideation using the Concise Health Risk Tracking scale. We performed latent Growth Mixture Modelling analysis to empirically identify trajectories of suicidal ideation. Multinomial logistic regression analyses were applied to estimate associations between trajectories and potential predictors. Results We identified four distinct trajectories. The Moderate-Stable group represented 11.1% and was characterized by constant suicidal ideation. The Moderate-Unstable group included 2.9% with persistent thoughts about suicide with a more fluctuating course. The third (Persistent-low, 20.8%) and fourth group (Persistent-very-low, 65.1%) were characterized by low levels of suicidal ideation. Higher depression scores and previous suicide attempts (non-significant trend) predicted membership of the Moderate-Stable group, whereas randomized treatment did not. Limitations No specific treatments against suicidal ideation were included and suicidal thoughts may persist for several years. Conclusion More than one in ten adult outpatients with bipolar disorder had moderately increased suicidal ideation throughout 6 months of pharmacotherapy. The identified predictors may help clinicians to identify those with additional need for treatment against suicidal thoughts and future studies need to investigate whether targeted treatment (pharmacological and non-pharmacological) may improve the course of persistent suicidal ideation.
AB - Introduction Suicidal ideation occurs frequently among individuals with bipolar disorder; however, its course and persistence over time remains unclear. We aimed to investigate 6-months trajectories of suicidal ideation among adults with bipolar disorder. Methods The Bipolar CHOICE study randomized 482 outpatients with bipolar disorder to 6 months of lithium- or quetiapine-based treatment including other psychotropic medications as clinically indicated. Participants were asked at 9 visits about suicidal ideation using the Concise Health Risk Tracking scale. We performed latent Growth Mixture Modelling analysis to empirically identify trajectories of suicidal ideation. Multinomial logistic regression analyses were applied to estimate associations between trajectories and potential predictors. Results We identified four distinct trajectories. The Moderate-Stable group represented 11.1% and was characterized by constant suicidal ideation. The Moderate-Unstable group included 2.9% with persistent thoughts about suicide with a more fluctuating course. The third (Persistent-low, 20.8%) and fourth group (Persistent-very-low, 65.1%) were characterized by low levels of suicidal ideation. Higher depression scores and previous suicide attempts (non-significant trend) predicted membership of the Moderate-Stable group, whereas randomized treatment did not. Limitations No specific treatments against suicidal ideation were included and suicidal thoughts may persist for several years. Conclusion More than one in ten adult outpatients with bipolar disorder had moderately increased suicidal ideation throughout 6 months of pharmacotherapy. The identified predictors may help clinicians to identify those with additional need for treatment against suicidal thoughts and future studies need to investigate whether targeted treatment (pharmacological and non-pharmacological) may improve the course of persistent suicidal ideation.
KW - Bipolar disorder
KW - Growth mixture modelling
KW - Suicidal ideation
KW - Trajectories
UR - http://www.scopus.com/inward/record.url?scp=85026228937&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85026228937&partnerID=8YFLogxK
U2 - 10.1016/j.jad.2017.07.038
DO - 10.1016/j.jad.2017.07.038
M3 - Article
C2 - 28755622
AN - SCOPUS:85026228937
SN - 0165-0327
VL - 223
SP - 146
EP - 152
JO - Journal of Affective Disorders
JF - Journal of Affective Disorders
ER -